Fatty liver disease (MASLD/MASH): open trials in Denmark

9 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

2024-512895-36-00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Trial Treatment · Phase 3 · Akero Therapeutics Inc.
Copenhagen University Hospital, Copenhagen Nv · Hvidovre Hospital, Hvidovre
Registry updated 2026-10-23
NCT06528314
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Hvidovre
Registry updated 2026-10-13
NCT05890365
Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
Research · Steno Diabetes Center Copenhagen
Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-06-11
NCT06819917
Identification of Liver Fibrosis Biomarkers
Research · Roche Diagnostics GmbH
Hvidovre Hospital, Copenhagen
Registry updated 2026-05-27
NCT05842850
Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
Trial Treatment · Steno Diabetes Center Copenhagen
steno diabetes center Aarhus, Aarhus · Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-05-04
NCT07246421
Glucagon Resistance in Patients With MASLD and T2DM
Trial Treatment · University of Aarhus
Aarhus University Hospital, Aarhus
Registry updated 2026-02-04
NCT03535142
Prognostic Significance of Fatty Liver Disease in Bariatric Patients
Trial Treatment · Esbjerg Hospital - University Hospital of Southern Denmark
Hospital of Southwest Jutland, Esbjerg
Registry updated 2025-03-05
NCT03308916
Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
Trial Treatment · Maja Thiele
Department of Gastroenterology and Hepatology, Odense University Hospital, Odense
Registry updated 2022-09-01
NCT05335603
An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Research · University of Copenhagen
Hvidovre University Hospital, Hvidovre
Registry updated 2022-04-19

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error